References
- Bahukudumbi P, Carson KH, Rice-Ficht AC, Andrews MJ. On the diameter and size distributions of bovine serum albumin (BSA)-based microspheres. J Microencapsulation 2004; 21: 787–803
- Bernard NG SS, Kessler WV, Landolt RR, Peck GE, Dockerty GH. Distribution and degradation of iodine-125 albumin microspheres and technetium-99m sulphur colloid. Can J Pharm Sci 1980; 15: 30–34
- Charles AH. Modern plastics Handbook. McGraw-Hill, New York 2000
- Dinarvand R, Mahmoodi S, Farboud E. Effect of process variables on particle size of gelatin microspheres containing lactic acid. Pharm Dev Tech 2005; 9: 291–299
- Egbaria K, Friedman M. Sustained release albumin microspheres containing antibacterial drugs: Effects of preparation conditions on kinetics of drug release. J Contr Rel 1990; 14: 79–94
- Gallo JM, Hung CT, Perrier DG. Analysis of albumin microsphere preparation. Int J Pharm 1984; 22: 63–74
- Ghassabian S, Ehtezazi T, Forutan SM, Mortazavi SA. Dexamethasone-loaded magnetic albumin microspheres: Preparation and in vitro release. Int J Pharm 1996; 130: 49–55
- Gupta PK, Hung CT. Albumin microspheres. I: Physico-chemical characteristics. J Microencapsulation 1989; 6: 427–462
- Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 1961; 50: 874–875
- Kohri N, Iwasa K, Kurihara J, Miyazaki K, Arita T. Inter-subject variation in oral absorption of ketoprofen from controlled-release granules in rabbits. Int J Pharm 1989; 49: 213–221
- Kokki H, Karvinen M, Jekunen A. Pharmacokinetics of a 24-hour intravenous ketoprofen infusion in children. Acta Anaesthesiol Scand 2002; 46: 194–198
- Kondo A. Microcapsule processing and technology. Marcel Dekker Inc, New York 1979
- Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983; 15: 25–35
- Kumar V, Lewis SA, Mutalik S, Shenoy DB, Venkatesh, Udupa N. Biodegradable microspheres of curcumin for treatment of inflammation. Indian J Physiol Pharmacol 2002; 46: 209–117
- Ledwith AR. Suspension polymerization and its application to the preparation of polymer supports. Reactive Polym 1983; 1: 159–174
- Lee TK, Sokoloski TD, Royer GP. Serum albumin beads: An injectable, biodegradable system for the sustained release of drugs. Science 1981; 213: 233–235
- Luftensteiner CP, Schwendenwein I, Paul B, Eichler HG, Viernstein H. Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal administration to rats. J Contr Rel 1999; 57: 35–44
- MacAdam AB, Shafi ZB, James SL, Marriott C, Martin GP. Preparation of hydrophobic and hydrophilic albumin microspheres and determination of surface carboxylic acid and amino residues. Int J Pharm 1997; 151: 47–55
- Mathew STDS, Sandhya KV. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration. AAPS Pharm Sci Tech 2007; 8, (1) Article 14 (http://www.aapspharmscitech.org)
- Moffat ACOM, Widdop B. Clarke's analysis of drugs and poisons3rd. Pharmaceutical Press, London 2003
- Morimoto K, Katsumata H, Yabuta T, Iwanaga K, Kakemi M, et al. Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin. Eur J Pharm Sci 2001; 13: 179–185
- Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985; 60: 110–111
- Sahin S, Selek H, Ponchel G, Ercan MT, Sargon M, Hincal AA, Kash S. Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres. J Contr Rel 2002; 82: 345–358
- Scully DB. Scale up in suspension polymerization. J Appl Polym Sci 1976; 20: 2299–2303
- Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-[epsilon]-caprolactone microspheres and nanospheres: An overview. Int J Pharm 2004; 278: 1–23
- Sjoergen J. Rate control in drug therapy. Churchill Livingstone, Edinburgh, UK 1985
- Tomlinson E. Microsphere delivery systems for drugs targeting and controlled release. Int J Pharm Technol Prod Manuf 1983; 4: 49–57
- Zahirul MKI. Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: Challenges and opportunities. Int J Pharm 1996; 140: 131–143
- Zili Z, Sfar S, Fessi H. Preparation and characterization of poly-epsilon-caprolactone nanoparticles containing griseofulvin. Int J Pharm 2005; 294: 261–267
- Zolle I, Rhodes BA, Wagner Jr HN. Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation. Int J Appl Radiat Isot 1970; 21: 155–167